繁體
简体中文
繁體中文

海恩時富 HAIN

等待開盤 09-06 09:30:00 美东时间

1.815

-0.045

-2.42%

华盛通華盛通
立即下載
  • 最 高1.95
  • 今 開1.85
  • 成交量 77.22万股
  • 最 低 1.80
  • 昨 收 1.86
  • 總市值 1.64亿
  • 52周最高 9.43
  • 市盈率 --
  • 換手率 0.86%
  • 52周最低 1.30
  • 委 比 19.24%
  • 總股本 9025.35万
  • 歷史最高 70.65
  • 量 比 1.27
  • 振 幅 8.06%
  • 歷史最低 1.30
  • 每 手 1
  • 風險率 2.67%

個股概要

財務分析

公司資料

相關新聞

分紅派息

  • 分時圖
  • 日k
  • 周k
  • 月k

相關新聞

更多
  • Eli Lilly Co. Q2 FY2025 Earnings Transcript

    Eli Lilly delivered a strong Q2 2025 with 38% revenue growth and major clinical milestones, despite a selloff over obesity drug trial data.

    08-08 01:44

  • Hain Celestial Announces Fiscal 2025 Fourth Quarter and Full Year Results Conference Call and Webcast

    Hain Celestial Group, a global health and wellness company, will release its fiscal fourth quarter and full year financial results on September 15, 2025, and host a conference call at 8:00 AM ET. The webcast and presentation will be available on the company’s website at www.hain.com. Investors and analysts can join the call via phone, while media and public can only listen. A replay will be available through September 22. Hain Celestial, headquar...

    08-06 20:15

  • Bath & Body Works Launches in Over 600 College Campuses Nationwide

    Bath & Body Works is expanding its reach by placing products in over 600 college campus stores nationwide, targeting Gen Z students. The program offers top fragrances like Champagne Toast and Warm Vanilla Sugar in various forms, including body care, candles, and sanitizers, to bring comfort to dorm life. This initiative is part of the brand's strategy to connect with younger consumers, leveraging its popularity among teens as the No. 1 fragrance ...

    08-06 13:00

  • Demystifying Hain Celestial Group: Insights From 6 Analyst Reviews

    In the latest quarter, 6 analysts provided ratings for Hain Celestial Group (NA...

    07-28 20:00

  • Mizuho Maintains Neutral on Hain Celestial Group, Lowers Price Target to $2.5

    Mizuho analyst John Baumgartner maintains Hain Celestial Group (NASDAQ:HAIN) with a Neutral and lowers the price target from $3 to $2.5.

    07-28 19:12

  • The Herzfeld Caribbean Basin Fund, Inc. Pays Distribution

    The Herzfeld Caribbean Basin Fund (NASDAQ: CUBA) announced a distribution of $0.2325 per share under its Managed Distribution Policy. The distribution included approximately 80% in shares and 20% in cash, with a total of $731,093.39 distributed in cash and 1,187,755 shares issued. Stockholders who elected cash received $0.09418 per share, while those opting for shares received approximately 0.0944 shares. The Fund aims to provide a 15% annual dis...

    06-30 20:00

  • Food processors pressured by GIS results, Hawley lashes out at Tyson...again

    Weighed down by General Mills’ (GIS) soft organic sales and downbeat outlook, shares within the packaged food category are trading defensively on Wednesday, driving the Consumer Staples SPDR (XLP) low...

    06-26 00:48

  • 12 Consumer Staples Stocks Moving In Monday's After-Market Session

    Gainers Casey's General Stores (NASDAQ:CASY) shares moved upwards by 8.4% to $...

    06-10 05:05

  • 美股大行评级 | 潜在涨幅417.8%!RBC Capital上调Perspective Therapeutics目标价至16美元,维持"跑赢大市"评级

    <span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1136940401951563776.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• RBC Capital:维持Perspective Therapeutics(CATX)"跑赢大市"评级,目标价从15美元升至16美元</p> <p>• Canaccord Genuity:维持Taysha Gene Th

    06-04 08:35

  • 美股大行评级 | 英伟达、赛富时、C3.ai、Veeva Systems等获多家机构上调目标价!

    <span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1135136987677396993.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通:维持Cogent Biosciences(COGT)"超配"评级,目标价从21美元升至25美元</p> <p>• Chardan Capital:维持Taysha Gene Therapies(TSHA)"买入"

    05-30 09:09